Neil S. Belloff
General Counsel at ACORDA THERAPEUTICS, INC.
Net worth: - $ as of 30/03/2024
Profile
Neil S.
Belloff is currently the Secretary & General Counsel at Acorda Therapeutics, Inc. He previously worked as the Senior Corporate Counsel at Celgene Corp.
and as the Executive VP, US Corporate & Securities Counsel at Deutsche Telekom AG.
From 2020 to 2021, he served as the COO, Secretary, EVP & General Counsel at Eloxx Pharmaceuticals, Inc. Mr. Belloff completed his undergraduate studies at Queens College and his graduate studies at New York University.
He also obtained a graduate degree from Quinnipiac University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/04/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Neil S. Belloff active positions
| Companies | Position | Start |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | General Counsel | 07/11/2021 |
Former positions of Neil S. Belloff
| Companies | Position | End |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Chief Operating Officer | 24/08/2021 |
| CELGENE | Corporate Officer/Principal | - |
| DEUTSCHE TELEKOM AG | Corporate Officer/Principal | - |
Training of Neil S. Belloff
| Queens College | Undergraduate Degree |
| New York University | Graduate Degree |
| Quinnipiac University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| DEUTSCHE TELEKOM AG | Communications |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Neil S. Belloff
